Wang O - Search Results

1

Expression profile analysis of long noncoding RNA in HER-2-enriched subtype breast cancer by next-generation sequencing and bioinformatics.

Yang F, Lyu S, Dong S, Liu Y, Zhang X, Wang O. Yang F, et al. Among authors: wang o. Onco Targets Ther. 2016 Feb 12;9:761-72. doi: 10.2147/OTT.S97664. eCollection 2016. Onco Targets Ther. 2016. PMID: 26929647 Free PMC article.

2

[One stage thyroidectomy and bilateral neck dissection for well-differentiated thyroid carcinoma].

Pan YF, Zhang XH, Ye GH, Lin BR, Chen XM, Jia XJ, Zhou SM, Wang OC. Pan YF, et al. Zhonghua Zhong Liu Za Zhi. 2006 May;28(5):389-92. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 17045009 Chinese.

3

[Quantitative detection of DD3 mRNA in prostate cancer tissues by real-time fluorescent quantitative reverse transcription polymerase chain reaction].

Tao ZH, Mao XL, Wang CH, Chen XD, Yu KY, Weng ZL, Hu YP, Zhang XH, Xie H, Wang OC, Song QT, Li CD, Chen ZG. Tao ZH, et al. Zhonghua Nan Ke Xue. 2007 Feb;13(2):130-3. Zhonghua Nan Ke Xue. 2007. PMID: 17345768 Clinical Trial. Chinese.

4

Clinical significance of Neutrophil gelatinase-associated lipocalin(NGAL) expression in primary rectal cancer.

Zhang XF, Zhang Y, Zhang XH, Zhou SM, Yang GG, Wang OC, Guo GL, Yang GY, Hu XQ. Zhang XF, et al. BMC Cancer. 2009 May 6;9:134. doi: 10.1186/1471-2407-9-134. BMC Cancer. 2009. PMID: 19419554 Free PMC article.

5

[Expression and its clinical significance of miR-155 in human primary breast cancer].

Zhu J, Hu XQ, Guo GL, Zhang Y, Wang OC, You J, Huang QD, Zhang XH. Zhu J, et al. Zhonghua Wai Ke Za Zhi. 2010 Feb 1;48(3):205-8. Zhonghua Wai Ke Za Zhi. 2010. PMID: 20388420 Chinese.

6

The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma.

Lin KL, Wang OC, Zhang XH, Dai XX, Hu XQ, Qu JM. Lin KL, et al. Ann Surg Oncol. 2010 Dec;17(12):3294-300. doi: 10.1245/s10434-010-1129-6. Epub 2010 Oct 15. Ann Surg Oncol. 2010. PMID: 20953721

7

Factors predictive of papillary thyroid micro-carcinoma with bilateral involvement and central lymph node metastasis: a retrospective study.

Zhou YL, Gao EL, Zhang W, Yang H, Guo GL, Zhang XH, Wang OC. Zhou YL, et al. World J Surg Oncol. 2012 May 19;10:67. doi: 10.1186/1477-7819-10-67. World J Surg Oncol. 2012. PMID: 22540396 Free PMC article.

8

Preoperative BRAF mutation is predictive of occult contralateral carcinoma in patients with unilateral papillary thyroid microcarcinoma.

Zhou YL, Zhang W, Gao EL, Dai XX, Yang H, Zhang XH, Wang OC. Zhou YL, et al. Asian Pac J Cancer Prev. 2012;13(4):1267-72. doi: 10.7314/apjcp.2012.13.4.1267. Asian Pac J Cancer Prev. 2012. PMID: 22799316 Free article.

9

Overexpression of miR-221 is associated with aggressive clinicopathologic characteristics and the BRAF mutation in papillary thyroid carcinomas.

Zhou YL, Liu C, Dai XX, Zhang XH, Wang OC. Zhou YL, et al. Med Oncol. 2012 Dec;29(5):3360-6. doi: 10.1007/s12032-012-0315-8. Epub 2012 Aug 2. Med Oncol. 2012. PMID: 22855362

10

Effectiveness of OK-432 (Sapylin) to reduce seroma formation after axillary lymphadenectomy for breast cancer.

Yang Y, Gao E, Liu X, Ye Z, Chen Y, Li Q, Qu J, Dai X, Wang O, Pan Y, Zhang X. Yang Y, et al. Among authors: wang o. Ann Surg Oncol. 2013 May;20(5):1500-4. doi: 10.1245/s10434-012-2728-1. Epub 2012 Oct 28. Ann Surg Oncol. 2013. PMID: 23104710 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

667 results

Search Page

Filters